Integrins in cancer: biological implications and therapeutic opportunities

By J. Desgrosellier, D. Cheresh. Nature Reviews. Cancer, 2010

3,622 citations recorded by the source corpus.

The integrin family of cell adhesion receptors regulates a diverse array of cellular functions crucial to the initiation, progression and metastasis of solid tumours. The importance of integrins in several cell types that affect tumour progression has made them an appealing target for cancer therapy. Integrin antagonists, including the αvβ3 and αvβ5 inhibitor cilengitide, have shown encouraging activity in Phase II clinical trials and cilengitide is currently being tested in a Phase III trial in patients with glioblastoma. These exciting clinical developments emphasize the need to identify how integrin antagonists influence the tumour and its microenvironment.

Subfields: Immunology, Immunology and Allergy, Oncology

View Paper: https://www.semanticscholar.org/paper/acf11375c001308ec88fc59b211e51a713d1a719

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. T. Cox
  2. F. Giancotti
  3. J. Erler
  4. Jonathan M Cooper
  5. Soo-Hyun Kim
  6. J. Turnbull
  7. S. Guimond
  8. F. Danhier

In Immunology and Allergy

  1. Rakesh K. Jain
  2. Peter Carmeliet
  3. Valerie M. Weaver
  4. C. Mas-Moruno
  5. F. Rechenmacher
  6. Horst Kessler
  7. T. Cox
  8. Jonathan M Cooper

In Oncology

  1. Rakesh K. Jain
  2. Peter Carmeliet
  3. F. Danhier
  4. V. Préat
  5. T. Cox
  6. J. Erler
  7. Olivier Féron
  8. F. Giancotti

Citations in the corpus